Clinical Research Directory
Browse clinical research sites, groups, and studies.
Therapy for Scabies With Two Differently Concentrated Permethrin Creams
Sponsor: Infectopharm Arzneimittel GmbH
Summary
The multi-center, prospective, randomized, double-blind phase III clinical trial will primarily investigate the efficacy and safety of treatment of scabies with Permethrin Cream 5% (approved drug InfectoScab 5% Cream) in direct comparison with Permethrin Cream 10%. The trial participants will be randomly assigned and blinded to either Permethrin Cream 5% or Permethrin Cream 10%.
Official title: Phase III Multicenter, Prospective, Randomized, Double-blind Study Comparing the Efficacy and Safety of Therapy for Scabies With Two Differently Concentrated Permethrin Creams.
Key Details
Gender
All
Age Range
2 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2024-05
Completion Date
2028-12
Last Updated
2024-04-23
Healthy Volunteers
No
Conditions
Interventions
5% Permethrin Creme
At visit V0, the investigational cream is applied once topically to the whole body. For patients who are not cured at visit V1, i.e. 14 days later, the application is repeated analogously once at this time.
10% Permethrin Creme
At visit V0, the investigational cream is applied once topically to the whole body. For patients who are not cured at visit V1, i.e. 14 days later, the application is repeated analogously once at this time.